The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods

Martin Franklin1, Edna Foa, John S March

  • 1Center for the Treatment and Study of Anxiety, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Insights

This study compares sertraline, cognitive-behavior therapy (CBT), their combination, and placebo for treating pediatric obsessive-compulsive disorder (OCD). It assesses treatment effectiveness and durability in young patients.

Area of Science:

  • Child and Adolescent Psychiatry
  • Clinical Psychology
  • Pharmacology

Background:

  • Obsessive-compulsive disorder (OCD) affects 1 in 200 children and adolescents, causing significant functional impairment.
  • Selective serotonin reuptake inhibitors (SSRIs) and cognitive-behavior therapy (CBT) show efficacy, but partial response and treatment durability vary.
  • Understanding optimal treatment strategies for pediatric OCD is crucial.

Purpose of the Study:

  • To evaluate the relative benefits and durability of sertraline, CBT, combination therapy, and placebo in children and adolescents with OCD.
  • To compare short-term efficacy and long-term outcomes of different treatment modalities.
  • To inform clinical practice for pediatric OCD management.

Main Methods:

  • A multicenter, randomized, masked clinical trial involving 120 subjects aged 7-17 with OCD.
  • Stage 1: 12-week randomized comparison of sertraline, CBT, combination, and placebo.
  • Stage 2: Open follow-up for responders, with tailored open-label treatment for non-responders or relapsed patients.

Main Results:

  • The study design allows for a rigorous comparison of four distinct treatment arms.
  • It investigates both immediate treatment response and the durability of effects after treatment discontinuation.
  • Data will elucidate differential outcomes between medication, therapy, and combination approaches.

Conclusions:

  • The Pediatric OCD Treatment Study provides a robust design to compare leading treatments for pediatric OCD.
  • Findings will clarify the comparative effectiveness and long-term utility of sertraline, CBT, and their combination.
  • This research aims to optimize treatment selection for improved patient outcomes.